Schooner Capital

Type

Venture Capital

Status

Active

Location

Boston, United States

Total investments

64

Average round size

40M

Portfolio companies

39

Rounds per year

1.21

Lead investments

19

Follow on index

0.39

Exits

9

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceInternetSoftwareInformation TechnologyHealth CareSaaSManufacturingMedicalPharmaceutical

Summary

In 1971 was created Schooner Capital, which is appeared as VC. The main department of described VC is located in the Boston. The venture was found in North America in United States.

The current fund was established by Vin Ryan. The overall number of key employees were 2.

The higher amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 26 percentage points more often commits exit comparing to other organizations. This Schooner Capital works on 15 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the Schooner Capital, startups are often financed by Tribeca Venture Partners, Rainfall Ventures, Lerer Hippeau. The meaningful sponsors for the fund in investment in the same round are Highland Capital Partners, Tribeca Venture Partners, Rainfall Ventures. In the next rounds fund is usually obtained by Highland Capital Partners, Western Technology Investment, VTF Capital.

We can highlight the next thriving fund investment areas, such as Biotechnology, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most popular portfolio startups of the fund, we may highlight Emerald Cloud Lab, Maxwell Health, Commonwealth Fusion.

Show more

Investor highlights

Industry focus
HealthcareInsurtechCloud/InfrastructureBiotech/Life Sciences
Stage focus
GeneralistPre-SeedSeedSeries ASeries B Show 1 more
Geo focus
Generalist

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
64
Lead investments
19
Exits
9
Rounds per year
1.21
Follow on index
0.39
Investments by industry
  • Health Care (17)
  • Biotechnology (15)
  • Software (14)
  • Information Technology (11)
  • Medical (10)
  • Show 73 more
Investments by region
  • United States (60)
  • United Kingdom (1)
  • Canada (1)
  • India (1)
  • Singapore (1)
Peak activity year
2017

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
12
Avg. valuation at time of investment
13M
Group Appearance index
0.58
Avg. company exit year
15
Avg. multiplicator
2.89
Strategy success index
0.10

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Brand Affinity Technologies 15 Aug 2008 Sports, Advertising, Media and Entertainment Early Stage Venture 1M United States, California, Irvine
Brixton Biosciences 14 May 2024 Biotechnology, Information Technology, Life Science Early Stage Venture 33M United States, Massachusetts, Cambridge
SeLux Diagnostics 12 Dec 2018 Health Care, Health Diagnostics Early Stage Venture 25M United States, Massachusetts, Boston

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.